RazeMath wins the annual New Venture Finals
UC Santa Barbara’s Technology Management department hosted the 2025 New Venture Finals, culminating eight months of interdisciplinary work from 44 student teams. RazeMath secured first place for its AI-driven math education program and took home $10,000 in the process. People’s Choice Winner for the event was Assistive Tech, which utilizes VR headsets to offer a Read More →
GreenSight Technologies takes home $125K at AngelCon
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sonos delivers earnings win, embraces new era
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
HRL shifts production to Camarillo
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MOU with India firm could help expand 101 biotech hub
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
FDA lifts clinical hold on Atara’s lead treatment
Thousand Oaks-based Atara Biotherapeutics received a bit of good news on May 5, after the U.S. Food and Drug Administration announced that it has lifted its hold on Atara’s active Investigational New Drug application for the Ebvallo program. Ebvallo, which is already approved in Europe and is used for transplant-related blood cancer, was placed on Read More →
805 Tech: Biotech Corridor Conference hits it out of the park for 3rd straight year
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
